Drugs / microfat
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03164122 | May 2017 → Jun 2018 | osteoarthritis | Assistance Publique Hopitaux De Marseille | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT05501743 | Feb 2023 → Feb 2026 | osteoarthritis | Assistance Publique Hopitaux De Marseille | Unknown | No outcome recorded |
| Phase 2 | NCT04010526 | Feb 2020 → Jul 2028 expected | perianal Crohn disease | Assistance Publique Hopitaux De Marseille | Recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT06084637 | Feb 2024 → Feb 2027 expected | osteoarthritis, knee | Assistance Publique Hopitaux De Marseille | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | microfat | “local co-administration of autologous ADIpose derived stromal vascular fraction and microfat for refractory perianal CROHN's fistulas Each batch of the final product is...” NCT04010526 ↗ |
| Modality | Other / unclassified | “autologous biological medicine” NCT03164122 ↗ |
| Route | Other | “intra-articular injection” NCT03164122 ↗ |